Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid.
Level 5 - mechanism / opinion, no new human data
Animal/bench research (mechanistic study in immature rats)
PubMed 19931336 · doi:10.1016/j.neuint.2009.11.011
What was done
Researchers measured cerebral cortex mitochondrial complex I activity, complex I protein content, assembly size, ATP production, and oxidative damage markers (3-nitrotyrosine, 4-hydroxynonenal, and protein carbonyls) in immature rats for up to 5 weeks following seizures induced by bilateral intracerebroventricular infusion of dl-homocysteic acid (600 nmol/side). They also assessed the effects of free radical scavengers and an mGluR8 agonist, (S)-3,4-DCPG, on complex I activity and epileptogenesis.
What was found
Seizures induced a selective ~60% decrease in mitochondrial complex I activity that persisted for up to 5 weeks without altering complex I assembled size or content. This was accompanied by a significant 15% to 30% increase in 3-nitrotyrosine, 4-hydroxynonenal, and protein carbonyls across the 5-week period. ATP production remained unimpaired. Complex I inhibition was substantially reduced by free radical scavengers and was attenuated by (S)-3,4-DCPG pretreatment, which also exerted a partial antiepileptogenic effect.
Why it matters
This work identifies sustained mitochondrial oxidative damage and complex I dysfunction as potential downstream drivers of epileptogenesis after early-life seizures, suggesting metabotropic glutamate receptor modulation and antioxidant pathways as candidate therapeutic targets.
Limits
The study was conducted in a chemical seizure model in immature rats and may not fully replicate human epileptogenesis. The abstract does not report the total number of animals (n) used, variance metrics (confidence intervals or standard deviations), or specific behavioral seizure frequencies.
Cited by
- supports Elevated homocysteine is metabolized into homocysteic acid, which acts as a mitochondrial toxin.